What is Viridian Therapeutics, Inc.'s debt-to-assets?

Viridian Therapeutics, Inc. (VRDN) reported debt-to-assets of 0× in Q1 2026.

How has Viridian Therapeutics, Inc.'s debt-to-assets changed year-over-year?

Viridian Therapeutics, Inc.'s debt-to-assets increased by 33.4% year-over-year, from 0× to 0×.

What is the long-term trend for Viridian Therapeutics, Inc.'s debt-to-assets?

Over 5 years (2020 to 2025), Viridian Therapeutics, Inc.'s debt-to-assets has grown at a 119.9% compound annual growth rate (CAGR), from 0× to 0×.

What does debt-to-assets mean?

Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.

Viridian Therapeutics, Inc. VRDN Debt-to-assets

Debt-to-assets at other companies

AmgenAMGN

0.6×0.0×

Immunovant, Inc.IMVT

0×0.0×

ANI PharmaceuticalsANIP

0.2×0.0×

Vir Biotechnology, Inc.VIR

0.1×0.0×

Nektar TherapeuticsNKTR

0.1×-0.3×

Syndax PharmaceuticalsSNDX

0.7×+0.2×

Other financials

Income statement

See full

Revenue$141.0K+95.8%

Operating income-$116.2M-23.8%

Net income-$104.9M-20.7%

EPS (diluted)-$1.15-5.5%

Balance sheet

See full

Cash & equivalents$176.3M+51.7%

Total debt$36.8M+59.4%

Total equity$636.0M+5.2%

Total assets$789.0M+19.4%

Cash flow

See full

Operating cash flow-$119.7M-29.1%

CapEx$23.0K-73.3%

Free cash flow-$119.7M-29.0%

Valuation

See full

Market cap$1.91B+82.0%

Enterprise value$1.77B+85.0%

P/S26.9×-3,445×

Profitability

See full

Gross margin36.3%—

Operating margin-543.9%-271pp

Net margin-508.5%-254pp

FCF margin-428.4%-214pp

Returns & leverage

See full

Return on equity-58.1%+7.9pp

Debt / equity0.1×0.0×

Current ratio15.1×-4.3×

Where this comes from

Calculated from Viridian Therapeutics, Inc.’s reported figures.

total debt/total assets=0×

Based on the most recent quarter.

The official record: Viridian Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viridian Therapeutics, Inc.'s debt-to-assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Viridian Therapeutics, Inc.'s debt-to-assets?: Viridian Therapeutics, Inc. (VRDN) reported debt-to-assets of 0× in Q1 2026.
How has Viridian Therapeutics, Inc.'s debt-to-assets changed year-over-year?: Viridian Therapeutics, Inc.'s debt-to-assets increased by 33.4% year-over-year, from 0× to 0×.
What is the long-term trend for Viridian Therapeutics, Inc.'s debt-to-assets?: Over 5 years (2020 to 2025), Viridian Therapeutics, Inc.'s debt-to-assets has grown at a 119.9% compound annual growth rate (CAGR), from 0× to 0×.
What does debt-to-assets mean?: Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.